Castellum (Castellum) ROCE % : -48.18% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Castellum ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Castellum's annualized ROCE % for the quarter that ended in Mar. 2024 was -48.18%.

Castellum ROCE % Historical Data

The historical data trend for Castellum's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Castellum ROCE % Chart

Castellum Annual Data

Trend

Sep10

Sep11

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-34.85

-43.67

-39.64

-66.68

Castellum Quarterly Data
	Jun10	Sep10	Dec10	Jun11	Sep11	Dec11	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial														-67.11	-16.92	-29.00	-166.30	-48.18

Castellum ROCE % Calculation

Castellum's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-15.808	/	( ( (33.043 - 7.759)	+	(30.107 - 7.977) )	/ 2 )
	=	-15.808	/	( (25.284	+	22.13)	/ 2 )
	=	-15.808	/	23.707
	=	-66.68 %

Castellum's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-10.684	/	( ( (30.107 - 7.977)	+	(30.472 - 8.25) )	/ 2 )
	=	-10.684	/	( ( 22.13	+	22.222 )	/ 2 )
	=	-10.684	/	22.176
	=	-48.18 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Castellum (AMEX:CTM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Castellum ROCE % Related Terms

Thank you for viewing the detailed overview of Castellum's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Castellum (Castellum) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Castellum Inc (AMEX:CTM) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814

Website

http://www.castellumus.com

Castellum Inc, formerly BioNovelus Inc is engaged in acquiring and growing technology companies in the areas of information technology and cybersecurity with businesses in the public (government) and private (commercial) markets. The company's services include intelligence analysis, software development, software engineering, program management, strategic planning, information assurance, and cybersecurity and policy along with analysis support.

Executives

Mark C Fuller	director, officer: Chief Executive Officer, Chair	9722 MEYER POINT DRIVE, POTOMAC MD 20854
Jay O Wright	director, officer: See Remarks	6701 DEMOCRACY BOULEVARD, SUITE 300, BETHESDA MD 20817
Charles Thomas Mcmillen	director	1103 SOUTH CAROLINA AVENUE, WASHINGTON DC 20003
Bernard S Champoux	director	1300 CRYSTAL DRIVE, PH1, ARLINGTON VA 22202
Mark S Alarie	director	8514 COUNTRY CLUB DRIVE, BETHESDA MD 20817
Patricia Frost	director	9 FERNGLEN DRIVE, THE WOODLANDS TX 77380
John Francis Campbell	director	8700 BITTERROOT CT., LORTON VA 22079
Emil Kaunitz	director	242 OVAL ROAD, MANASQUAN NJ 08736
David T Bell	officer: Chief Financial Officer	1016 GLYNDON ST. E, VIENNA VA 22180
Laurie M Buckhout	director, officer: Chief Revenue Officer	210 BLAIR COURT, EDENTON NC 27932
Glen R Ives	officer: Chief Operating Officer	34 PHILLIPS AVENUE, PONTE VEDRA BEACH FL 32082